Valuation : Ipsen

Market Cap 1.35TCr 1.57TCr 1.27TCr 1.16TCr 2.17TCr 1,48200Cr 2.18TCr 15TCr 5.83TCr 76TCr 5.89TCr 5.76TCr 2,44900Cr P/E 2026 *
13.7x
P/E 2027 * 14x
Enterprise Value 1.23TCr 1.43TCr 1.15TCr 1.05TCr 1.97TCr 1,34600Cr 1.98TCr 14TCr 5.29TCr 69TCr 5.35TCr 5.24TCr 2,22400Cr EV / Sales 2026 *
2.7x
EV / Sales 2027 * 2.42x
Free-Float
40.65%
Yield 2026 *
0.93%
Yield 2027 * 0.93%
1 day-2.31%
1 week+0.98%
Current month+0.98%
1 month+4.97%
3 months+6.67%
6 months+0.61%
Current year+38.40%
1 week 160.8
Extreme 160.8
170.9
1 month 153.7
Extreme 153.7
170.9
Current year 116
Extreme 116
174
1 year 109.9
Extreme 109.9
174
3 years 87.95
Extreme 87.95
174
5 years 77
Extreme 77
174
10 years 34.2
Extreme 34.2
174
Manager TitleAgeSince
Chief Executive Officer 59 01/07/2020
Chief Executive Officer 57 01/01/2020
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 61 30/08/2005
Chairman 68 22/11/2010
Director/Board Member 69 01/06/2012
Date Insider Type Main position Quantity % Market Cap. Importance
24/08/26 Sell

Chairman

-3,840 0.0046%
18/08/26 Sell

Chief Executive Officer

-1,000 0.0012%
17/08/26 Sell

Chief Executive Officer

-2,000 0.0024%
Change 5-day change 1-year change 3-year change Capi.($)
-2.31%+0.98%+37.36%+42.11% 1.57TCr
-0.88%-2.15%+54.71%+106.31% 1,02400Cr
-1.15%+2.68%+53.97%+71.50% 66TCr
-1.44%+0.38%+20.40%+73.05% 45TCr
+0.14%-0.47%+29.49%+38.56% 35TCr
-1.33%+4.72%+24.69%+45.55% 30TCr
-1.15%+0.30%-1.49%+12.31% 25TCr
-1.55%+1.11%+56.10%+70.32% 24TCr
-0.88%+1.15%-17.09%-54.39% 21TCr
-0.15%+3.65%+33.90%+96.99% 19TCr
Average -1.12%+1.08%+29.20%+50.23% 36.94TCr
Weighted average by Cap. -1.11%+0.55%+36.63%+66.12%

Financials

2026 *2027 *
Net sales 454.34Cr 528Cr 427.47Cr 390.5Cr 730.5Cr 50TCr 732.49Cr 5.05TCr 1.96TCr 26TCr 1.98TCr 1.94TCr 82TCr 463.7Cr 538.87Cr 436.28Cr 398.54Cr 745.54Cr 51TCr 747.58Cr 5.16TCr 2TCr 26TCr 2.02TCr 1.98TCr 84TCr
Net income 101.07Cr 117.46Cr 95Cr 87Cr 162.5Cr 11TCr 162.95Cr 1.12TCr 436.04Cr 5.69TCr 441.06Cr 431.44Cr 18TCr 99Cr 114.51Cr 93Cr 85Cr 158.43Cr 11TCr 158.87Cr 1.1TCr 425.12Cr 5.55TCr 430.01Cr 420.63Cr 18TCr
Net Debt -123.8Cr -143.87Cr -116.48Cr -106.4Cr -199.05Cr -14TCr -199.59Cr -1.38TCr -534.1Cr -6.97TCr -540.24Cr -528.46Cr -22TCr -229.94Cr -267.22Cr -216.34Cr -197.63Cr -369.71Cr -25TCr -370.71Cr -2.56TCr -992.03Cr -13TCr -1TCr -981.55Cr -42TCr
Logo Ipsen
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows: - oncology (69.2%); - neuroscience (20.3%); - rare diseases (10.5%). At the end of 2025, the group had 7 research and development centers located in France (2), the United Kingdom (2), China (2) and Ireland, and 5 manufacturing sites worldwide. Net sales are distributed geographically as follows: France (8%), Europe (31.7%), the United States (32.9%), North America (2.2%) and other (25.2%).
Employees
5,535
Date Price Change Volume
04/26/04 €164.70 -2.31% 86,307
03/26/03 €168.60 +0.54% 86,251
02/26/02 €167.70 0.00% 86,028
01/26/01 €167.70 +2.82% 96,017
31/26/31 €163.10 0.00% 1,08,721
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
164.70EUR
Average target price
167.07EUR
Spread / Average Target
+1.44%

Quarterly revenue - Rate of surprise